Pfizer/BioNTech and Moderna

FDA Reprimands Officials Seeking To Alter Vaccine Dosing Schedule

  • FDA said that the idea of changing the authorized dosing or schedules of COVID-19 vaccines was premature and not supported by the available data.
  • The FDA said it had been following discussions and news reports about reducing the number of doses and extending the length of time between doses.
  • The discussions were also on cutting the dosage in half, or mixing and matching vaccines in order to immunize more people.

The U.S. Food and Drug Administration, in a press announcement, delivered a clear...

https://mfame.guru/fda-reprimands-officials-seeking-to-alter-vaccine-dosing-schedule/

Oxford Vaccine Effectivity on Elderly & Severe COVID Patients Slows Approval

  • Shot prevents severe disease, but more data needed on over-55s.
  • Many scientists underline limitations of the vaccine.
  • They are going slow with the approval to get more data on elderly and severe patients.
  • So far there is a lack of clarity because of varied data. 

According to a Bloomberg report, on the day Britain began immunizing its population with a Covid-19 shot developed by Germany’s BioNTech SE and the U.S.’s Pfizer Inc., a peer-reviewed study of the U.K.’s homegrown vaccine left some...

https://mfame.guru/oxford-vaccine-effectivity-on-elderly-severe-covid-patients-slows-approval/